Commerce Bank’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.94M Buy
64,642
+5,092
+9% +$547K 0.04% 260
2025
Q1
$6.01M Sell
59,550
-2,046
-3% -$206K 0.04% 273
2024
Q4
$5.5M Sell
61,596
-395
-0.6% -$35.3K 0.03% 293
2024
Q3
$5.19M Sell
61,991
-256
-0.4% -$21.5K 0.03% 307
2024
Q2
$4.79M Sell
62,247
-289
-0.5% -$22.3K 0.03% 313
2024
Q1
$4.28M Sell
62,536
-221
-0.4% -$15.1K 0.03% 350
2023
Q4
$3.63M Sell
62,757
-1,240
-2% -$71.7K 0.03% 365
2023
Q3
$3.38M Sell
63,997
-917
-1% -$48.4K 0.03% 353
2023
Q2
$3.51M Buy
64,914
+42
+0.1% +$2.27K 0.03% 353
2023
Q1
$3.25M Sell
64,872
-981
-1% -$49.1K 0.03% 364
2022
Q4
$3.05M Sell
65,853
-1,832
-3% -$84.8K 0.02% 374
2022
Q3
$2.62M Sell
67,685
-592
-0.9% -$22.9K 0.02% 392
2022
Q2
$2.55M Sell
68,277
-12,784
-16% -$477K 0.02% 409
2022
Q1
$3.59M Buy
81,061
+1,459
+2% +$64.6K 0.02% 379
2021
Q4
$3.38M Buy
79,602
+901
+1% +$38.3K 0.02% 396
2021
Q3
$3.42M Buy
78,701
+2,329
+3% +$101K 0.02% 394
2021
Q2
$3.27M Buy
76,372
+30
+0% +$1.28K 0.02% 388
2021
Q1
$2.95M Sell
76,342
-13,835
-15% -$535K 0.02% 387
2020
Q4
$3.24M Buy
90,177
+411
+0.5% +$14.8K 0.03% 372
2020
Q3
$3.43M Sell
89,766
-7,449
-8% -$285K 0.03% 330
2020
Q2
$3.41M Sell
97,215
-3,976
-4% -$140K 0.03% 325
2020
Q1
$3.3M Buy
101,191
+2,252
+2% +$73.5K 0.04% 273
2019
Q4
$4.47M Buy
98,939
+6,724
+7% +$304K 0.04% 249
2019
Q3
$3.75M Buy
92,215
+1,710
+2% +$69.6K 0.04% 272
2019
Q2
$3.89M Buy
90,505
+1,599
+2% +$68.7K 0.04% 235
2019
Q1
$3.41M Buy
88,906
+9,924
+13% +$381K 0.04% 239
2018
Q4
$2.79M Buy
78,982
+4,480
+6% +$158K 0.04% 244
2018
Q3
$2.87M Buy
74,502
+951
+1% +$36.6K 0.03% 249
2018
Q2
$2.41M Buy
73,551
+35,012
+91% +$1.14M 0.03% 272
2018
Q1
$1.05M Buy
38,539
+1,009
+3% +$27.6K 0.01% 399
2017
Q4
$931K Sell
37,530
-722
-2% -$17.9K 0.01% 419
2017
Q3
$1.12M Buy
38,252
+28,449
+290% +$830K 0.02% 388
2017
Q2
$272K Buy
9,803
+1,471
+18% +$40.8K ﹤0.01% 708
2017
Q1
$207K Buy
+8,332
New +$207K ﹤0.01% 769